First evaluation in multiple sclerosis using PET tracer [18F]3F4AP demonstrates heterogeneous binding across lesions.

Saved in:
Bibliographic Details
Title: First evaluation in multiple sclerosis using PET tracer [18F]3F4AP demonstrates heterogeneous binding across lesions.
Authors: Tiss A; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA., Michaelson NM; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA., Russo AW; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA., Ramos-Torres KM; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA., Sun Y; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA., DaSilva NE; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA., Noel JM; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA., Liu F; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA., Gong K; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA., Huang SY; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA., Popko B; Feinberg School of Medicine, Department of Neurology, Northwestern University, Chicago, IL, 60611, USA., Baker S; Department of Cellular and Tissue Imaging, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA., Klawiter EC; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. eklawiter@mgh.harvard.edu., Brugarolas P; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. pbrugarolas@mgh.harvard.edu.
Source: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2026 Jan; Vol. 53 (2), pp. 1125-1138. Date of Electronic Publication: 2025 Aug 05.
Publication Type: Clinical Trial, Phase I; Journal Article
Journal Info: Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first